Crystalline form of 1- (beta-D-glucopyranosyl) -4 -methyl3- [5- (4 -fluorophenyl) -2-thienylmethyl] benzene hemihydrate

Details for Australian Patent Application No. 2007329895 (hide)

Owner Mitsubishi Tanabe Pharma Corporation

Inventors Kawanishi, Eiji; Nomura, Sumihiro

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007329895

PCT Pub. Number WO2008/069327

Priority 2006-327019 04.12.06 JP; 60/868,426 04.12.06 US

Filing date 3 December 2007

Wipo publication date 12 June 2008

Acceptance publication date 8 September 2011

International Classifications

C07H 7/04 (2006.01) Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond

A61K 31/70 (2006.01) - Carbohydrates

Event Publications

2 July 2009 PCT application entered the National Phase

  PCT publication WO2008/069327 Priority application(s): WO2008/069327

8 September 2011 Application Accepted

  Published as AU-B-2007329895

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007329897-Molten metal continuous casting method

2007329879-Tricyclic compound and medical use thereof